(Q41737325)

English

Radiotherapy options for localized prostate cancer based upon pretreatment serum prostate-specific antigen levels and biochemical control: a comprehensive review of the literature

scientific article published on March 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

1 reference

Europe PubMed Central

Radiotherapy options for localized prostate cancer based upon pretreatment serum prostate-specific antigen levels and biochemical control: a comprehensive review of the literature (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

author name string

Vicini FA

1

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Horwitz EM

2

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Kini VR

3

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Stromberg JS

4

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Martinez AA

5

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

language of work or name

0 references

publication date

1 March 1998

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

1101-1110

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

The management of clinically localized prostate cancer: guidelines from the American Urological Association

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment options for localized prostate cancer based on pretreatment serum prostate specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

External beam radiation therapy does not offer long-term control of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Incidence and Significance of Detectable Levels of Serum Prostate Specific Antigen After Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen decline: a major prognostic factor for prostate cancer treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen nadir: the optimum level after irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum prostate-specific antigen in monitoring the response of carcinoma of the prostate to radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns-of-failure analysis of patients with high pretreatment prostate-specific antigen levels treated by radiation therapy: the need for improved systemic and locoregional treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of serum prostate specific antigen determinations before and after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Localized prostate cancer treated by external-beam radiotherapy alone: serum prostate-specific antigen--driven outcome analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen following radiotherapy for local prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical Prostatectomy and Radical Radiation Therapy for Clinical Stages T1 to 2 Adenocarcinoma of the Prostate: New Insights into Outcome from Repeat Biopsy and Prostate Specific Antigen Followup

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Fast neutron radiotherapy for locally advanced prostate cancer. Final report of Radiation Therapy Oncology Group randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen deprivation and radiation therapy in prostate cancer: the evolving case for combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen following prostate radiotherapy: how low can you go?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen after external beam radiotherapy for prostatic cancer: followup.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of PSA levels in radiation therapy of patients with carcinoma of the prostate: the UCLA experience 1988-1992

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three-dimensional conformal radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/ml

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. I-125 implant followed by external-beam radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential benefit of improved local tumor control in patients with prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Laparoscopic pelvic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed implantation of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term freedom from disease progression after I-125 prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical disease-free survival following 125I prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Conformal mixed neutron and photon irradiation in localized and locally advanced prostate cancer: preliminary estimates of the therapeutic ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic implications of prostate-specific antigen in patients with locally advanced prostate cancer treated with high energy neutron beam therapy: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined hormonal and radiation therapy for lymph node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated conformal radiotherapy in locally advanced prostate cancer: results of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer (RTOG Protocol 90-20)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A method for determining a prostate-specific antigen cure after radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

PSA confirmation of cure at 10 years of T1B, T2, N0, M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Observations of pretreatment prostate-specific antigen doubling time in 107 patients referred for definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate Specific Antigen as an Outcome Variable for T1 and T2 Prostate Cancer Treated by Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen density is not an independent predictor of response for prostate cancer treated by conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer volume adds significantly to prostate-specific antigen in the prediction of early biochemical failure after external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen density in patients with histologically proven prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate specific antigen density as a prognostic factor for patients with prostate carcinoma treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen density: a new prognostic indicator for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Biopsy after External Beam Radiation Therapy for Adenocarcinoma of the Prostate: Correlation with Original Histological Grade and Current Prostate Specific Antigen Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic biopsies: do they add prognostic information in men with clinically localized prostate cancer treated with radiation therapy alone?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Transrectal ultrasonically-guided core biopsies in the assessment of local cure of prostatic cancer after radical external beam radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

PSA following irradiation for prostate cancer: the upcoming ASTRO symposium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pelvic radiation therapy on serum levels of prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2900942-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(97)00942-5

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41737325&oldid=1926699493"